An athlete’s heart and a charmer’s smile: meet Armond Maillard
March 21st is “Down Syndrome Awareness Day,” a day designated by the United Nations to…
Kate O’NeillMarch 17, 2023
Beyond Down Syndrome: The Friedman family turns experience into guidance
Parent, advocate, and published author, Steve Friedman has used his family's recent experiences to help…
Fierce Biotech article highlights dearth of inclusion in Alzheimer’s research
"Alzheimer's meds are here. But for the Down syndrome community, it's still the 1980s" by…
Kate O’NeillMarch 2, 2023
With support from Lilly, LuMind IDSC launches key research and awareness activities to advance Down syndrome research
2/22/2023 (Burlington, MA) – Today the LuMind IDSC Foundation, a leading national Down syndrome research…
Kate O’NeillFebruary 23, 2023
Statement on accelerated approval of Leqembi to treat mild-stage Alzheimer’s disease in the general population
On Friday, January 6, the U.S. Food & Drug Administration (FDA) granted accelerated approval for…
Kate O’NeillJanuary 10, 2023
New steps forward in treating Alzheimer’s disease with lecanemab: Clinical trial reveals clear efficacy in removing brain plaque
At an Alzheimer’s disease research conference last week, new clinical trial data was presented for…
Kate O’NeillDecember 5, 2022
DS-CTN Data and Safety Monitoring Board (DSMB)
LuMind IDSC and the Down Syndrome Clinical Trials Network are pleased to announce the launch…
Kate O’NeillNovember 16, 2022
Lecanemab: New Treatment for Alzheimer’s Disease
Eisai, a Japanese pharmaceutical company, and its partner Biogen, a Massachusetts-based biotechnology company, recently announced…
Kate O’NeillNovember 1, 2022
NTG Publishes Advisory on Long-COVID in Adults with Intellectual Disability
In a recent report, the National Task Group on Intellectual Disabilities and Dementia Practices (NTG)…
Kate O’NeillOctober 17, 2022
Random Acts of Kindness During Down Syndrome Awareness Month
Nowadays people with Down syndrome live healthier, longer, and more fulfilling lives than the generations…
Kate O’NeillOctober 6, 2022
